| Literature DB >> 24758530 |
Gail A Mountain, Daniel Hind1, Rebecca Gossage-Worrall, Stephen J Walters, Rosie Duncan, Louise Newbould, Saleema Rex, Carys Jones, Ann Bowling, Mima Cattan, Angela Cairns, Cindy Cooper, Rhiannon Tudor Edwards, Elizabeth C Goyder.
Abstract
BACKGROUND: Loneliness in older people is associated with poor health-related quality of life (HRQoL). We undertook a parallel-group randomised controlled trial to evaluate the effectiveness and cost-effectiveness of telephone befriending for the maintenance of HRQoL in older people. An internal pilot tested the feasibility of the trial and intervention.Entities:
Mesh:
Year: 2014 PMID: 24758530 PMCID: PMC4022155 DOI: 10.1186/1745-6215-15-141
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Figure 1Flow of participants through the study. aOne withdrawn by Chief Investigator due to protocol violation relating to eligibility; two withdrew consent shortly after allocation (one unhappy with involvement of service provider; one felt the study was not for them); five withdrew consent at the point of arranging 6 month follow-up (one due to ill health; one no longer unhappy so did not want to take part; one unhappy with the intervention - at this point they had not received any calls; one other reason - unhappy with being left uninformed about lack of intervention; one due to personal or family issues); one not contactable (minimum of six telephone attempts and reminder letter sent). bOne withdrew consent at the point of arranging 6 month follow-up (unhappy with allocated study arm); one not contactable (line dead, letter and email reminder sent); one on 4 week holiday; two refused (one felt no different so did not want to answer the same questions again; one was too ill). cTwo participants no longer wanted intervention (one was too busy; one thought intervention was not for them) and one participant did not give any reason for intervention withdrawal. dAssigned to intervention group 4 but the volunteer dropped out before intervention delivery. eOne withdrew consent at the point of arranging 6 months follow-up (unhappy with study arm allocation); one not contactable (no dial tone, letter and email reminder sent); one on four week holiday; two refused (one felt no different so did not want to answer the same questions again; one felt too ill). fTwo no longer wanted intervention (one was too busy; one thought intervention was not for them); one did not give any reason for intervention withdrawal. gAssigned to intervention group 4 but intervention not delivered as volunteer dropped out. ITT, intention-to-treat.
Participant baseline characteristics by randomised group (N = 70)
| | | ||||||
|---|---|---|---|---|---|---|---|
| Gender | Female | 23 | 66% | | 18 | 51% | |
| Male | 12 | 34% | | 17 | 49% | | |
| Total | 35 | 100% | | 35 | 100% | | |
| Ethnic group | White European | 35 | 100% | | 35 | 100% | |
| Live with others | No | 25 | 71% | | 27 | 77% | |
| Yes | 10 | 29% | | 8 | 23% | | |
| Total | 35 | 100% | | 35 | 100% | | |
| Main activity | Retired | 34 | 97% | | 35 | 100% | |
| Looking after home/family | 1 | 3% | | 0 | 0% | | |
| Total | 35 | 100% | | 35 | 100% | | |
| Occupation type | Professional | 13 | 38% | | 8 | 23% | |
| Managerial/Technical | 10 | 29% | | 10 | 29% | | |
| Skilled (non-manual) | 1 | 3% | | 6 | 17% | | |
| Skilled (manual) | 3 | 9% | | 3 | 9% | | |
| Partly skilled | 3 | 9% | | 4 | 11% | | |
| Unskilled | 4 | 12% | | 4 | 11% | | |
| Total | 34 | 100% | | 35 | 100% | | |
| | |||||||
| Age (years) | 35 | 81.8 | 5.8 | 35 | 80.1 | 3.7 | |
Occupation type was left blank by one participant (intervention group) as it was not applicable. They stated main activity as ‘Looking after home/family’).
Mean baseline participant reported outcomes by randomised group (N = 70)
| | ||||||
|---|---|---|---|---|---|---|
| | ||||||
| SF-36 Physical function | 35 | 65.6 | 27.4 | 35 | 67 | 27.3 |
| SF-36 Role physical | 35 | 71.3 | 25.2 | 35 | 73.6 | 25.3 |
| SF-36 Bodily pain | 35 | 64.4 | 29 | 35 | 64 | 26 |
| SF-36 General health | 35 | 69.2 | 21.4 | 35 | 60 | 19.4 |
| SF-36 Vitality | 35 | 62.3 | 20.3 | 35 | 54.3 | 21.4 |
| SF-36 Social function | 35 | 85 | 22.6 | 35 | 81.4 | 26 |
| SF-36 Role emotional | 35 | 88.6 | 19.2 | 35 | 86.4 | 24 |
| SF-36 Mental health | 35 | 77.9 | 17.5 | 35 | 74.7 | 21.6 |
| SF-36 Physical component summary | 35 | 43.8 | 10.5 | 35 | 43.7 | 11 |
| SF-36 Mental component summary | 35 | 54.1 | 9.1 | 35 | 51.3 | 12.5 |
| EQ-5D | 35 | 0.73 | 0.29 | 35 | 0.73 | 0.24 |
| EQ-5D VAS | 35 | 75.1 | 18.6 | 35 | 72.5 | 18.8 |
| De Jong emotional loneliness | 34 | 1.9 | 1.8 | 35 | 2.3 | 2 |
| De Jong social loneliness | 35 | 1.4 | 1.7 | 35 | 1.7 | 1.8 |
| De Jong overall loneliness | 34 | 3.3 | 3.1 | 35 | 4 | 3.5 |
| PHQ-9 | 35 | 2.9 | 3.6 | 35 | 3.3 | 4.8 |
| ONS wellbeing | 35 | 7.8 | 2.4 | 35 | 7.5 | 2.5 |
| GSE | 35 | 33.7 | 4.5 | 35 | 31.3 | 5.5 |
The Short Form (36) Health Instrument (SF-36) Dimensions are scored on a 0 (poor) to 100 (good) health scale, except for the Physical and Mental Component summary scores which are standardised to have a mean of 50 and SD of 10. The EuroQol 5-Dimension (EQ-5D) utility score is measured on a -0.56 to 1.00 (good health) scale. The EQ-5D visual analogue scale (VAS) is measured on a 0 (worst imaginable health state) to 100 (best imaginable health state). The emotional loneliness scale of the De Jong is scored on a 0 to 6 scale with higher scores indicating more loneliness. The social loneliness scale of the De Jong is scored on a 0 to 5 scale with higher scores indicating more loneliness. The total loneliness scale of the De Jong is scored on a 0 to 11 scale with higher scores indicating more loneliness. The Patient Health Questionnaire (PHQ)-9 is measured on a 0 to 27 scale with higher scores indicating more severe depressive symptoms. General Self-Efficacy (GSE) Scale is scored on a 10 to 40 scale with higher scores indicating more perceived self-efficacy.
The Office for National Statistics (ONS) instrument measures subjective well-being on a 0 to 40 scale, with higher scores indicating high subjective well-being.
One participant did not answer questions 5, 9 and 10 of the De Jong (reason recorded: participant did not want to answer) which affected the emotional and overall loneliness scores.
Figure 2Mean Short Form (36) (SF-36) Mental Health Dimension scores over time by randomised group.
Mean 6 month post-randomisation follow-up participant reported outcomes by randomised group (N = 56)
| | | | | | | | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | |||||||
| SF-36 Mental health | 26 | 77.5 | 18.4 | 30 | 70.7 | 21.2 | 6.5 | -3 | 16 | 9.5 | 4.5 | 14.5 |
| SF-36 Physical function | 26 | 60.3 | 29.9 | 30 | 56 | 29.9 | 3.4 | -10.8 | 17.5 | 5 | -0.9 | 10.9 |
| SF-36 Role physical | 26 | 72.6 | 24.7 | 30 | 55.4 | 27.6 | 15.6 | 3.8 | 27.4 | 20.2 | 9.9 | 30.6 |
| SF-36 Bodily pain | 26 | 71 | 26 | 30 | 53.9 | 29.8 | 17.1 | 2.5, | 31.7 | 16.6 | 8 | 25.3 |
| SF-36 General health | 26 | 66.2 | 24.2 | 30 | 56.1 | 22.9 | 10.3 | -1.2 | 21.9 | 2.5 | -6.4 | 11.4 |
| SF-36 Vitality | 26 | 59.4 | 19.8 | 30 | 49.6 | 25.5 | 9.8 | -2 | 21.7 | 3.1 | -2.8 | 9 |
| SF-36 Social function | 26 | 84.1 | 22.8 | 30 | 70 | 31.1 | 13.4 | 1.4 | 25.4 | 18.1 | 7.9 | 28.3 |
| SF-36 Role emotional | 26 | 89.1 | 19.4 | 30 | 81.7 | 23.9 | 7.4 | -3.1 | 17.9 | 8.6 | -0.8 | 18 |
| SF-36 Physical component summary | 26 | 43.5 | 10.9 | 30 | 38.3 | 11.5 | 5.1 | -0.4 | 10.7 | 4.5 | 1.4 | 7.5 |
| SF-36 Mental component summary | 26 | 53.9 | 9.8 | 30 | 49.7 | 11.5 | 4.1 | -0.5 | 8.7 | 4.7 | 2 | 7.5 |
| EQ-5D | 26 | 0.73 | 0.35 | 29 | 0.71 | 0.27 | -0.04 | -0.17 | 0.1 | 0.02 | -0.05 | 0.09 |
| EQ-5D VAS | 26 | 75.5 | 19.5 | 30 | 70.5 | 21.8 | 4.7 | -4.6 | 14 | 5.1 | -4.9 | 15.2 |
| De Jong emotional loneliness | 26 | 2.2 | 2 | 30 | 2.2 | 1.9 | 0.2 | -0.5 | 0.9 | 0 | -0.6 | 0.6 |
| De Jong social loneliness | 25 | 1.3 | 1.9 | 30 | 1.2 | 1.5 | -0.1 | -0.7 | 0.5 | 0.3 | -0.2 | 0.8 |
| De Jong overall loneliness | 26 | 3.5 | 3.4 | 30 | 3.3 | 2.9 | 0 | -1 | 1 | 0.6 | -0.4 | 1.6 |
| PHQ-9 (6 months) | 26 | 3.1 | 4 | 30 | 3.6 | 4.6 | -0.4 | -2.2 | 1.3 | -1.3 | -2.6 | 0 |
| ONS wellbeing | 26 | 8 | 1.5 | 30 | 7.6 | 1.8 | 0.5 | -0.2 | 1.2 | 0.8 | 0.2 | 1.4 |
| GSE | 26 | 32.9 | 4.7 | 30 | 32.1 | 3.8 | 0.8 | -1.5 | 3.2 | 1.2 | -0.7 | 3.1 |
The Short Form (36) Health Instrument (SF-36) Dimensions are scored on a 0 (poor) to 100 (good) health scale. The EuroQol 5-Dimension (EQ-5D) utility score is measured on a -0.56 to 1.00 (good health) scale, except for the Physical and Mental Component summary scores which are standardised to have a mean of 50 and a SD of 10. The EQ-5D visual analogue scale (VAS) is measured on a 0 (worst imaginable health state) to 100 (best imaginable health state). The emotional loneliness scale of the De Jong is scored on a 0 to 6 scale with higher scores indicating more loneliness. The social loneliness scale of the De Jong is scored on a 0 to 5 scale with higher scores indicating more loneliness. The total loneliness scale of the De Jong is scored on a 0 to 11 scale with higher scores indicating more loneliness. The Patient Health Questionnaire (PHQ)-9 is measured on a 0 to 27 scale with higher scores indicating more severe depressive symptoms. General Self-Efficacy (GSE) Scale is scored on a 10 to 40 scale with higher scores indicating more perceived self-efficacy. The Office for National Statistics (ONS) instrument measures subjective well-being on a 0 to 40 scale, with higher scores indicating high subjective well-being.
Models are general linear mixed model with befriending group included as a random effect. *Unadjusted: fixed covariate is randomised group only. **Adjusted: fixed covariates are randomised group, baseline score, age and gender.
Mean observed and imputed 6-month post-randomisation follow-up SF-36 MH outcomes by randomised group (N = 70)
| | | | | | | | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | |||||||
| Observed data (N = 56) | 26 | 77.5 | 18.4 | 30 | 70.7 | 21.2 | 6.5 | -3.0 | 16.0 | 9.5 | 4.5 | 14.5 |
| LOCF imputed data (N = 70)) | 35 | 78 | 16.6 | 35 | 69.6 | 22.5 | 8.3 | -0.5 | 17.2 | 7.7 | 3.7 | 11.8 |
| Regression imputed data (N = 70) | 35 | 77.8 | 16.2 | 35 | 69.8 | 21.4 | 7.8 | -0.6 | 16.2 | 7.6 | 3.6 | 11.6 |
| Multiple imputation PMM (N = 70) | 35 | 78.9 | 3.7 | 35 | 70.6 | 3.7 | 8.3 | -0.6 | 17.2 | 8.0 | 2.8 | 13.3 |
| Multiple imputation regression (N = 70) | 35 | 77.3 | 3.2 | 35 | 69.7 | 3.9 | 7.6 | -1.8 | 16.9 | 7.4 | 1.8 | 13.0 |
| Per protocol data (N = 39) | 9 | 73.9 | 17.5 | 30 | 70.7 | 21.2 | 3.2 | -5.2 | 11.6 | 8.0 | 3.3 | 12.7 |
The Short Form (36) Health Instrument Mental Health Dimension (SF-36 MH) is scored on a 0 (poor) to 100 (good) health scale. All analyses use a marginal general linear model, with regression coefficients estimated using generalised estimating equations, with robust standard errors. Regression imputation based on a model with age sex and baseline Mental Health score. Multiple imputation based on 20 imputed data sets, with age, sex and baseline score as covariates, using predictive mean matching (PMM) or linear regression. *For the multiple imputation methods the SD is the standard error of the mean. **Adjusted for randomised group, age, sex and baseline score. LOCF, last observation carried forward.
Figure 3Forest plot of sensitivity analysis of mean difference in Short Form (36) Health Instrument (SF-36) mental health outcome between groups. LOCF, last observation carried forward; PMM, predictive mean matching.